R2P MISAGO SXR06100RRecalls & reported problems
Terumo Corporation · MISAGO RX Self-expanding Peripheral Stent · Class 3 · Implant
All models of R2P MISAGO (13)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 04987350727541), received between Jun 28, 2022 and Nov 30, 2023 — classified as 3 injuries.
The most frequently reported specific device problem is “Material Deformation” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Material Deformation3
Patient problems
- No Clinical Signs, Symptoms or Conditions3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryNov 30, 2023Material Deformation; Material Deformation
THE USER FACILITY REPORTED THAT A 6X100 MISAGO WAS DEPLOYED IN DISTAL SUPERFICIAL FEMORAL ARTERY (SFA) AREA WHERE SOME PLAQUE DISSECTION WAS PRESENT. UPON DEPLOYMENT THE PROXIMAL END OF THE STENT APPEARED TO BE CRIMPED. THIS MALFORMATION OF DEPLOYMENT WAS NOT FLOW LIMITING, HOWEVER IT WAS A CONCERN FOR THE DOCTOR AFTER PLACEMENT. HE FURTHER INVESTIGATED AND SHOWED UNDER INTRAVASCULAR ULTRASOUND (IVUS) THAT THE FLUOROSCOPY IMAGE WAS CONFIRMED, AND THE TOP OF THE STENT WAS CRIMPED. THE DOCTOR WAS NOT SATISFIED WITH THE STENT AND REALIGNED THE MISAGO WITH A 6X40 ZILVER PTX STENT. THE ARTERY OF THE LOWER EXTREMITY WAS NOT PREVIOUSLY TREATED. RIGHT SUPERFICIAL FEMORAL ARTERY (SFA) WAS DISEASED LIMB. SITE OF THE PUNCTURE WAS THE FEMORAL ARTERY CONTRALATERAL VIA ANTEGRADE APPROACH. THE LESION LENGTH 100, WITH A 5MM VESSEL DIAMETER. THE PATIENT WAS STABLE, AND THE PROCEDURE OUTCOME WAS SUCCESSFUL.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18239352 ↗InjuryOct 25, 2022Material Deformation; Material Deformation
THE USER FACILITY REPORTED THAT THE PATIENT NEEDED A RIGHT DISTAL SUPERFICIAL FEMORAL ARTERY (SFA) TO MILD POPLITEAL INTERVENTION. AN ATHERECTOMY WAS DONE WITH A DRUG COATED BALLOON (DCB) TO MID POP TO DISTAL RIGHT SFA, AND STENT FROM MID TO DISTAL SFA. THE ACCESS WAS A CUT DOWN TO THE RIGHT PROXIMAL SFA WITH A SHORT 7 FRENCH SHEATH ANTEGRADE POSITIONED. THE VESSEL WAS 6MM IN DIAMETER AND 150MM IN LENGTH WAS NEEDED. WHEN THE STENT WAS DEPLOYED, THE STENT DID NOT ELONGATE. AFTER DEPLOYMENT, IT SHORTENED. THE STENT LENGTH WAS NOT ENOUGH, AND ANOTHER MISAGO STENT WAS PLACED PROXIMALLY. HOWEVER, IT WAS FORESHORTENED ALSO. THE STENT LENGTH WAS 100MM. THE DOCTOR USED A THIRD STENT TO COVER THE LENGTH TO THE MID SFA. THE STENT WAS A ZILVER BALLOON EXPANDING STENT. THE PATIENT'S VESSEL WAS FULLY OPPOSED, AND FLOW WAS NOT LIMITED. PRIOR TO THE INTERVENTION THE VESSEL WAS A CHRONIC TOTAL OCCLUSION (CTO). THE CASE WAS SUCCESSFUL. THE PATIENT WAS IN STABLE CONDITION. THE PROCEDURE WAS A SUCCESSFUL INTERVENTION OF RIGHT SFA. THE ARTERY OF THE LOWER EXTREMITY WAS NOT PREVIOUSLY TREATED. THE LESION TREATMENT HISTORY WAS DE NOVO. THE RIGHT LIMB WAS DISEASED. THE CALCIFICATION WAS MODERATE. TORTUOU
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15668463 ↗InjuryJun 28, 2022Material Deformation; Material Deformation
THE USER FACILITY REPORTED THAT A 6X100 MISAGO WAS DEPLOYED IN DISTAL SUPERFICIAL FEMORAL ARTERY (SFA) AREA WHERE SOME PLAQUE DISSECTION WAS PRESENT. UPON DEPLOYMENT THE PROXIMAL END OF THE STENT APPEARED TO BE CRIMPED. THIS MALFORMATION OF DEPLOYMENT WAS NOT FLOW LIMITING, HOWEVER IT WAS A CONCERN FOR THE DOCTOR AFTER PLACEMENT. HE FURTHER INVESTIGATED AND SHOWED UNDER INTRAVASCULAR ULTRASOUND (IVUS) THAT THE FLUOROSCOPY IMAGE WAS CONFIRMED, AND THE TOP OF THE STENT WAS CRIMPED. THE DOCTOR WAS NOT SATISFIED WITH THE STENT AND REALIGNED THE MISAGO WITH A 6X40 ZILVER PTX STENT. THE ARTERY OF THE LOWER EXTREMITY WAS NOT PREVIOUSLY TREATED. RIGHT SUPERFICIAL FEMORAL ARTERY (SFA) WAS DISEASED LIMB. SITE OF THE PUNCTURE WAS THE FEMORAL ARTERY CONTRALATERAL VIA ANTEGRADE APPROACH. THE LESION LENGTH 100, WITH A 5MM VESSEL DIAMETER. THE PATIENT WAS STABLE, AND THE PROCEDURE OUTCOME WAS SUCCESSFUL.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14849203 ↗
Other STENT, SUPERFICIAL FEMORAL ARTERY devices
- EverFlex™ EVD35-06-150-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 death110 reports
- SUPERA S-60-150-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY108 reports
- SUPERA S-55-150-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY88 reports
- LifeStent® Solo Vascular Stent EX062003CLBard Peripheral Vascular, Inc. · STENT, SUPERFICIAL FEMORAL ARTERY80 reports
- BioMimics 3D Vascular Stent System 144700-12Veryan Medical Limited · Stent, Superficial Femoral Artery74 reports
- SUPERA S-50-120-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY55 reports
- EverFlex™ EVD35-07-060-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 recall5 reports
- EverFlex™ EVD35-07-120-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 recall5 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page